A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Aminorex
Penfluridol
The risk or severity of QTc prolongation can be increased when Penfluridol is combined with Entrectinib.
Aminorex
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Entrectinib.
Aminorex
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Entrectinib.
Aminorex
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Entrectinib.
Aminorex
Terodiline
The risk or severity of QTc prolongation can be increased when Terodiline is combined with Entrectinib.
Aminorex
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Entrectinib.
Aminorex
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Entrectinib.
Aminorex
Lorcainide
The risk or severity of QTc prolongation can be increased when Lorcainide is combined with Entrectinib.
Aminorex
Bunaftine
The risk or severity of QTc prolongation can be increased when Bunaftine is combined with Entrectinib.
Aminorex
Lorajmine
The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Entrectinib.
Aminorex
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Entrectinib.
Aminorex
Prajmaline
The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Entrectinib.
Aminorex
Nizofenone
The risk or severity of QTc prolongation can be increased when Nizofenone is combined with Entrectinib.
Aminorex
Otilonium
The risk or severity of QTc prolongation can be increased when Otilonium is combined with Entrectinib.
Aminorex
Bencyclane
The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Entrectinib.
Aminorex
Cibenzoline
The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Entrectinib.
Aminorex
Sultopride
The risk or severity of QTc prolongation can be increased when Sultopride is combined with Entrectinib.
Aminorex
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Sitafloxacin is combined with Entrectinib.
Aminorex
Macimorelin
The risk or severity of QTc prolongation can be increased when Macimorelin is combined with Entrectinib.
Aminorex
Gallopamil
The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Entrectinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3